Methotrexate selectively modulates TH1/TH2 balance in active rheumatoid arthritis patients.

Abstract

Our data suggest that, in active RA patients, apoptosis induction by MTX may be primarily due to IL-10 production via modulation of oxidative stress, which may restore the critically important immune balance. These findings may contribute to determining which group of RA patients may better respond to MTX therapy.